Seagen, A Wholly Owned Subsidiary Of Pfizer

This early-phase study tested a new drug, PF-08046045, in 22 adults with advanced lymphomas that had not responded to standard treatments. The main goal was to check safety and side effects, and to find the best dose. The study was terminated early, so results are limited.

This trial tested a drug called tisotumab vedotin, alone or with other medicines, in 214 people with cervical cancer that had come back or spread. The goal was to find safe doses and see if the drug shrinks tumors. The study was ended early, but results may still help guide futur…